These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 8354301

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Quinolone resistance of Escherichia coli strains isolated from urinary tract infections].
    Agulla A, Montes I.
    Enferm Infecc Microbiol Clin; 1994; 12(6):322. PubMed ID: 8080877
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vivo activity of ciprofloxacin, ofloxacin, norfloxacin and pipemidic acid against Escherichia coli infections in mice.
    Obana Y, Nishino T.
    Drugs Exp Clin Res; 1989; 15(2):53-8. PubMed ID: 2661182
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Quinolone resistance among Escherichia coli strains from community-acquired urinary tract infections in Greece.
    Chaniotaki S, Giakouppi P, Tzouvelekis LS, Panagiotakos D, Kozanitou M, Petrikkos G, Avlami A, Vatopoulos AC, WHONET Study Group.
    Clin Microbiol Infect; 2004 Jan; 10(1):75-8. PubMed ID: 14706091
    [Abstract] [Full Text] [Related]

  • 7. Sequential mutations of gyrA in Escherichia coli associated with quinolone therapy.
    Truong QC, Ouabdesselam S, Hooper DC, Moreau NJ, Soussy CJ.
    J Antimicrob Chemother; 1995 Dec; 36(6):1055-9. PubMed ID: 8821606
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Norfloxacin versus pipemidic acid in complicated urinary tract infections due to susceptible pathogens: a comparative clinical trial.
    Del Favero A, Frongillo RF, Menichetti F, Boldrini F, Guerciolini R, Pauluzzi S.
    Chemioterapia; 1986 Apr; 5(2):88-91. PubMed ID: 3518966
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
    Piccolomini R, Cellini L, Allocati N, Di Girolamo A, Selan L, Scazzocchio F.
    Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H, Azap OK, Ergönül O, Timurkaynak F, Urinary Tract Infection Study Group.
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity of quinolones against isolates from paediatric urinary tract infections from three Venezuelan centres.
    Rodríguez AJ, Rodríguez CN, Meijomil P, García A, Duque C, Molina N, Barbella R, Lakatos M, Bellorin E, Mendoza M.
    Int J Antimicrob Agents; 2001 Jun; 17(6):531-2. PubMed ID: 11397626
    [No Abstract] [Full Text] [Related]

  • 16. Acute uncomplicated UTI and E. coli resistance: implications for first-line empirical antibiotic therapy.
    Perfetto EM, Keating K, Merchant S, Nichols BR.
    J Manag Care Pharm; 2004 Jun; 10(1):17-25. PubMed ID: 14720102
    [Abstract] [Full Text] [Related]

  • 17. Quinolone resistance in female outpatient urinary tract isolates of Escherichia coli: age-related differences.
    Gobernado M, Valdés L, Alós JI, Garcia-Rey C, Dal-Ré R, García-de-Lomas J, Spanish Surveillance Group for E. coli Urinary Pathogens.
    Rev Esp Quimioter; 2007 Jun; 20(2):206-10. PubMed ID: 17893757
    [Abstract] [Full Text] [Related]

  • 18. Association between fluoroquinolone resistance and resistance to other antimicrobial agents among Escherichia coli urinary isolates in the outpatient setting: a national cross-sectional study.
    Hwang TJ, Hooper DC.
    J Antimicrob Chemother; 2014 Jun; 69(6):1720-2. PubMed ID: 24521853
    [No Abstract] [Full Text] [Related]

  • 19. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
    Smith JT.
    Scand J Infect Dis Suppl; 1986 Jun; 49():115-23. PubMed ID: 3547618
    [Abstract] [Full Text] [Related]

  • 20. Resistance to quinolones in pathogens causing urinary tract infections.
    Kapoor H, Aggarwal P.
    J Commun Dis; 1997 Sep; 29(3):263-7. PubMed ID: 9465532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.